Impact of Donor Left Ventricular Geometric Remodeling and Hypertrophy on Heart Acceptance and Recipient Survival

Christian O'Donnell1, Juka S Kim2, Akansha Tarun1

  • 1Division of Cardiothoracic Anesthesiology, Stanford University School of Medicine, Stanford, California, USA.

JACC. Heart Failure
|May 20, 2026
PubMed

Insights

Classifying donor hearts by geometric remodeling, not just wall thickness, may increase acceptance rates without impacting patient survival. This study analyzed donor heart remodeling patterns and their effect on transplant outcomes.

Area of Science:

  • Cardiology
  • Transplant Surgery
  • Medical Imaging

Background:

  • Current donor heart screening relies solely on left ventricular (LV) wall thickness, overlooking diverse geometric remodeling patterns.
  • These patterns, crucial in other cardiovascular conditions, haven't been assessed in donor heart evaluation.

Purpose of the Study:

  • To determine the prevalence of LV geometric remodeling patterns in brain-dead donor hearts.
  • To evaluate the clinical impact of these patterns on donor heart acceptance and recipient survival.

Main Methods:

  • Utilized echocardiograms from 3,647 brain-dead donors (February 2015-May 2020) in the Donor Heart Study (DHS).
  • Classified LV geometric remodeling using American Society of Echocardiography (ASE) guidelines.
  • Compared remodeling patterns and LV wall thickness (>1.3 cm) with transplant acceptance and 3-year recipient mortality via multivariable modeling.

Main Results:

  • Concentric remodeling was the most frequent pattern (58.5%).
  • Increased LV wall thickness often indicated concentric remodeling (52.1%), not solely concentric hypertrophy (43.8%).
  • Neither LV wall thickness, concentric remodeling, nor concentric hypertrophy significantly correlated with 3-year recipient survival.

Conclusions:

  • Classifying donor hearts by LV geometric remodeling patterns could potentially decrease rejections due to perceived "hypertrophy."
  • This refined assessment may expand the donor pool without negatively affecting patient outcomes.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...